Dedicated to being the advertising destination for insights, analytics, and marketing, this year’s Re!Think conference will prove that Insight Changes Everything.
This paper provides an overview of the treatment approaches for Multiple Sclerosis (MS) in 2016, together with an exploration of the current market dynamics and how they have evolved in recent years. It concludes with two case studies: 'Tecfidera: Still The Wonder Drug?' and 'Analysing Key Market Drivers'.